Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2021 - 11 - 20    source : Jaguarhealth.gcs-web.com    save search
Jaguar Health Announces Topline Results of Investigator-Initiated Phase 2 Study of Crofelemer for Prevention of Chemotherapy-Induced Diarrhea (CID) in Breast Cancer Patients
Published: 2021-11-19 (Crawled : 16:20) - jaguarhealth.gcs-web.com
JAGX | $0.158 -10.79% -12.09% 30M twitter stocktwits trandingview |
Health Technology
 | | O: 1.72% H: 6.44% C: 2.37%
phase 2 diarrhea therapy results cancer topline breast cancer initiated crofelemer
Gainers vs Losers
64% 36%

Top 10 Gainers
AGBA | News | $1.305 226.25% 130M twitter stocktwits trandingview |
Finance
EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services
NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services
INSG | $3.03 25.21% 330K twitter stocktwits trandingview |
Electronic Technology
KNW 4 | $0.59 -0.71% 18.64% 27K twitter stocktwits trandingview |
Manufacturing
GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing
ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |

UONE | $2.36 19.8% 16.53% 75K twitter stocktwits trandingview |
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.